Replies to post #190664 on Kraig Biocraft Laboratories Inc (KBLB)

[DimesForShares]

How many negatives? Let me count the ways.

1) A failure of the end-of-year crop that evidently left Prodigy without any ability to produce silk.

2) A lack of capital for growth and expansion.

3) The continuing threat of a reverse split, even in the absence of fundamentals needed for uplisting.

4) A lack of capital for continuing operations.

5) A setback due to covid-19 that will prevent KBLB from reaching their modest goal of 8 tons for 2020.

6) Management that cannot effectively communicate important developments to shareholders in a manner that generates enthusiasm.

7) The threat of competition from Randy Lewis and his Chinese collaborators.

8) Negative shareholder equity of around $6 million and growing.

There are so many positives happening right now that the share price should be double from it is trading right now. So, your analysis is not only incorrect, but it is the complete opposite of what is truly happening

Predicting the share price 'should be' twice as high as it is and using the price it should be to prove one's argument is mind-boggling. Perhaps the true situation is that shareholders recognize these many negatives, balanced against the potential of KBLB, and that weighs down on the share price. Any analysis that indicates our share price should be double where it actually is cannot be realistic. Start from where the share price is right now and explain that.

A modest shipment of silk to Polartec in mid- to late-August will only affect a couple of the negatives associated with KBLB. We are not going to soar into dollars-per-share territory when Polartec gets a shipment of 800 kilos or so of silk, IMHO.

Go KBLB. Or at least get started. Please!!!